Boehringer Ingelheim Launches Highly Affordable Unbranded Humira Biosimilar

Boehringer Ingelheim Launches Highly Affordable Unbranded Humira Biosimilar

German pharmaceutical company Boehringer Ingelheim has made a major move in the biosimilar market by introducing an unbranded version of…

Read More »